What are cafestol and kahweol?

Cafestol and kahweol are two lipid diterpenes naturally present in coffee bean oils. They are the only known dietary compounds that increase LDL cholesterol in a dose-dependent and measurable way. Their impact depends entirely on preparation method: a paper filter retains 97 to 99 % of these compounds and practically eliminates their effect on cholesterol; unfiltered preparations (French press, boiled coffee, espresso without paper filter) release them fully into the cup.

Cafestol and kahweol belong to the diterpene family — hydrophobic lipid molecules found primarily in the oily fraction of coffee beans. They are present in both Arabica and Robusta, albeit in slightly different proportions. Their discovery as hypercholesterolaemic agents dates to the 1990s, through Dutch research that had noticed cholesterol increases in countries where boiled coffee (Scandinavian kaffekoker or Turkish coffee) was prevalent.

The mechanism of action of cafestol is well elucidated. It inhibits a nuclear receptor in the liver called FXR (Farnesoid X receptor), a key regulator of bile acid metabolism. By disrupting this system, cafestol reduces the liver's capacity to clear LDL-cholesterol from the bloodstream, causing it to accumulate. Controlled studies have shown that consuming French press coffee at 4 cups per day for 4 weeks can increase LDL-cholesterol by 6 to 10 % — a clinically significant shift.

Kahweol acts through a complementary mechanism but shares the same lipid regulatory pathways. Recent studies also attribute anti-carcinogenic properties to it in certain cell models, notably for liver and colon cancers, by inhibiting phase II enzymes of xenobiotic metabolism. These potentially beneficial properties of kahweol illustrate the complexity of coffee's health profile: the same compound can be detrimental for cholesterol but potentially protective against other pathologies.

Practical impact is entirely determined by filtration method. Paper filter is the only one that effectively retains cafestol and kahweol: its micropores (0.3 to 0.5 mm) block the oil droplets containing these diterpenes. Metal filters (used in French presses, Mokas, some espressos) let the oils pass through. Cloth filters (used in Portuguese and Brazilian traditions) have intermediate efficacy.

Quantitatively, one espresso contains on average 2 to 4 mg cafestol, one French press cup 4 to 7 mg, one cup of Scandinavian boiled coffee 7 to 10 mg, and one paper-filtered cup less than 0.5 mg. For a consumer with cardiovascular risk or under lipid monitoring, these values are clinically relevant: 4 cups of French press per day — 16 to 28 mg cafestol — can cause an LDL increase of 0.13 to 0.25 mmol/L over several weeks.

Espresso deserves special mention: although prepared without paper filter, the very small cup volume (25–30 ml) means the absolute amount of cafestol ingested per serving remains relatively low compared to a large French press cup. One or two espressos per day therefore presents a more limited risk than several large plunger coffee cups.

Cafestol content by preparation method

The French press cholesterol connection and its clinical significance

The clinical connection between unfiltered coffee consumption and elevated LDL cholesterol was established through several landmark studies beginning with Dutch epidemiologist Martijn Katan's work in the 1990s. Katan and colleagues demonstrated that boiled (unfiltered) coffee consumption raised LDL cholesterol by measurable amounts in controlled feeding studies — a finding that held up across multiple replications and explained why Scandinavian countries with high rates of boiled coffee consumption showed different cardiovascular risk profiles than comparable populations drinking filtered coffee. The mechanism, subsequently identified as cafestol and kahweol, provided the biological explanation for an epidemiological observation that had been puzzling for decades.

The dose-response relationship is clinically relevant. Consuming 4–5 cups of French press or boiled coffee per day raises LDL cholesterol by approximately 6–8% on average — equivalent to roughly 0.3–0.4 mmol/L in absolute terms. For most healthy adults with normal baseline cholesterol, this increase is unlikely to cause cardiovascular events. For individuals with already-elevated LDL, or those managing familial hypercholesterolaemia, the additional LDL burden from unfiltered coffee is a genuine clinical consideration worth discussing with a physician. The relevant recommendation for at-risk individuals is not to eliminate coffee but to switch brewing method — paper filter brewing removes over 95% of cafestol and kahweol, making filtered coffee essentially neutral for LDL even at 4–5 cups daily.

Going deeper

The paradox of cafestol and kahweol's other biological activities complicates the simple 'unfiltered coffee raises cholesterol' narrative. Both diterpenes have demonstrated anti-inflammatory, hepatoprotective and potentially anticarcinogenic properties in cell culture and animal studies. Cafestol is among the most potent inducers of cytoprotective enzymes identified in the food supply — a finding that has prompted coffee researchers to describe its biological activity as more complex than the LDL story alone suggests. Whether the anti-inflammatory and hepatoprotective activities of cafestol represent a meaningful health benefit that partially offsets its LDL-raising activity in humans is not yet established by clinical trial evidence. The honest summary: for LDL management, filter your coffee; for overall antioxidant exposure, unfiltered coffee provides compounds that filtered coffee does not — whether these compounds' benefits outweigh their LDL costs depends on individual health context.